WS6 induces both alpha and beta cell proliferation without affecting differentiation or viability

Endocrine Journal
Brian P BoernerNora E Sarvetnick

Abstract

Agents that stimulate human pancreatic beta cell proliferation are needed to improve diabetes mellitus treatment. Recently, a small molecule, WS6, was observed to stimulate human beta cell proliferation. However, little is known about its other effects on human islets. To better understand the role of WS6 as a possible beta cell regenerative therapy, we carried out in-depth phenotypic analysis of WS6-treated human islets, exploring its effects on non-beta cell proliferation, beta cell differentiation, and islet cell viability. WS6 not only stimulated beta cell proliferation in cultured human islets (in agreement with previous reports), but also human alpha cell proliferation, indicating that WS6 is not a beta cell-specific mitogen. WS6 did not change the proportion of insulin-positive beta cells or the expression of beta cell-specific transcription factors, suggesting that WS6 does not alter beta cell differentiation, and WS6 had no effect on human islet cell apoptosis or viability. In conclusion, WS6 stimulates proliferation of both human beta and alpha cells while maintaining cellular viability and the beta cell differentiated phenotype. These findings expand the literature on WS6 and support the suggestion that WS6 may help ...Continue Reading

References

Feb 26, 1976·The New England Journal of Medicine·R S SherwinP Felig
Apr 1, 1970·The Journal of Clinical Investigation·R H UngerA M Eisentraut
Jan 10, 2002·The Journal of Biological Chemistry·Marcela BrissovaAlvin C Powers
May 3, 2003·The Journal of Clinical Endocrinology and Metabolism·Kun Ho YoonSusan Bonner-Weir
Sep 17, 2004·The Journal of Clinical Investigation·Rohit N KulkarniC Ronald Kahn
Aug 23, 2008·Proceedings of the National Academy of Sciences of the United States of America·Helga EllingsgaardMarc Y Donath
Jan 24, 2009·Proceedings of the National Academy of Sciences of the United States of America·Weidong WangPeter G Schultz
Aug 12, 2009·Proceedings of the National Academy of Sciences of the United States of America·Rodolfo Guardado-MendozaFranco Folli
Apr 9, 2010·Cell Metabolism·Chunyan GuJacqueline E Lee
Feb 2, 2011·PloS One·Zhuo LiuJosephine M Egan
Apr 6, 2011·Diabetologia·J C Henquin, J Rahier
Dec 14, 2011·Journal of Biomolecular Screening·Deepika WalpitaBridget K Wagner
Feb 22, 2012·Proceedings of the National Academy of Sciences of the United States of America·Justin P AnnesDouglas A Melton
Jul 20, 2012·International Journal of Endocrinology·Amedeo Vetere, Bridget K Wagner
Jan 22, 2013·Journal of the American Chemical Society·Weijun ShenPeter G Schultz
Jul 19, 2013·The Journal of Clinical Investigation·Shuangli GuoRoland Stein
Sep 17, 2013·Cell Reports·Brandon L TaylorMaike Sander
Oct 4, 2013·Diabetes·Yousef El-GoharyGeorge Gittes

❮ Previous
Next ❯

Citations

Sep 13, 2016·Diabetes, Obesity & Metabolism·J Shirakawa, R N Kulkarni
Aug 20, 2016·Therapeutic Advances in Endocrinology and Metabolism·Elisa CorritorePhilippe A Lysy
Oct 24, 2018·Scientific Reports·Jin XuChong Hyun Shin
Jun 30, 2019·Current Diabetes Reports·Giorgio BasileNoel G Morgan
Nov 5, 2021·Molecular Biology Reports·Saeedeh AkhavanGhodratollah Panahi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis